5-AMINO-1MQ
NNMT is expressed in several tissues, including adipose tissue, and has become an area of interest in metabolic research because of its relationship with cellular energy balance, NAD+ metabolism, and methylation pathways. Researchers have investigated whether inhibiting NNMT may influence how cells manage energy and metabolic resources.
Preclinical studies involving NNMT inhibition have explored potential effects on adipose tissue metabolism, energy expenditure, body composition, glucose regulation, and metabolic function. 5-Amino-1MQ has therefore attracted research interest in areas involving obesity, metabolic dysfunction, and cellular energy regulation.
Research into 5-Amino-1MQ remains experimental. Its mechanisms, safety profile, long-term effects, and potential applications in humans have not been fully established, and research findings should not be interpreted as evidence of an approved therapeutic or weight-loss benefit.
For laboratory research purposes only. Not for human consumption
Neelakantan et al., 2018, Scientific Reports: This is one of the key studies on 5-Amino-1MQ. Researchers investigated selective NNMT inhibition in adipocytes and diet-induced obese mice, including effects on body weight, adipose tissue and metabolic processes.
Neelakantan et al., 2024: This later animal study specifically evaluated 5A1MQ in diet-induced obese mice. Researchers reported effects on fat-mass gain, glucose tolerance, insulin sensitivity and liver metabolic measures.
PubMed: NNMT inhibition and obesity-related metabolic dysfunction
Review: Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes: Useful background for explaining why NNMT is being investigated in metabolic research, including its relationship with NAD+, adipose biology and glucose metabolism.
